News | January 09, 2015

CHI Franciscan Health Designated As The First Northwest Accredited Heart Failure System

Healthcare Colloquium was chosen as accreditation body because of framework that enables standardized best practices and coordination of care

heart Failure, CHI Franciscan, Healthcare Colloquium

Image courtesy of PR Newswire

January 9, 2015 — The Healthcare Colloquium announced that CHI Franciscan Health is the first Accredited Heart Failure System in the Northwest.

St. Joseph Medical Center earned recognition as an Accredited Heart Failure Institute.

St. Elizabeth Hospital, St. Francis Hospital, St. Clare Hospital, St. Anthony Hospital and Harrison Medical Center became Accredited Heart Failure Centers.  CHI Franciscan Health is the third Accredited Heart Failure system through The Healthcare Colloquium.

The Healthcare Colloquium's unique heart failure accreditation process builds on the member hospital's prior improvement experience leading to initial heart failure accreditation. Member hospitals work within four established domains of heart failure: community, hospital, clinicians and science using The Healthcare Colloquium's continuum of care model that leads to:  

·  Integration of heart failure care; from antecedents to early diagnosis and advanced care

·  Streamlined processes across the entire continuum of care beginning in the community

·  Enabling individuals to participate in their own care with more independence and less hospitalization

·  Collaboration with other Colloquium member hospitals across the country

For more information:  www.chifranciscan.org

Related Content

EMPRISE Study Shows Empagliflozin Reduces Heart Failure Hospitalization with new data presented at AHA 2018. #AHA18 #AHA2018
News | Heart Failure | November 07, 2018
November 6, 2018 – Initial results from the real-world EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) s
Acute Heart Failure Mortality, Rehospitalizations Reduced With Blood Volume Measurement
News | Heart Failure | November 02, 2018
In a new study, acute heart failure patients who received individualized treatment by blood volume measurement with the...
Daxor Corp. Collaborating With CHF Solutions on Heart Failure Fluid Overload Management

CHF Solutions' Aquadex FlexFlow System

News | Heart Failure | November 01, 2018
November 1, 2018 — Daxor Corp.
NHLBI Pauses CONCERT-HF Heart Failure Trial
News | Heart Failure | October 29, 2018
The National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, is pausing the...
A patient who received the HeartMate III LVAD system showing off his external battery pack. He served as a patient ambassador in the Abbott booth at ACC 2018. The HeartMate III, with its magnetic levitated pump, showed a big reduction in clotting over previous LVADs in a key late-breaking trial at ACC earlier this year.

A patient who received the HeartMate III LVAD system showing off his external battery pack. He served as a patient ambassador in the Abbott booth at ACC 2018. The HeartMate III, with its magnetic levitated pump, showed a big reduction in clotting over previous LVADs in a key late-breaking trial at ACC earlier this year.

Feature | Heart Failure | October 19, 2018
October 19, 2018 — Abbott announced today that the HeartMate 3 Left Ventricular Assist Device (LVAD) has received U.S
Ohio State First in U.S. to Test Shunt Device for Heart Failure
News | Heart Failure | October 04, 2018
The Ohio State University Wexner Medical Center is first in the country to test a new medical device designed to help...
Mitral Regurgitation Volume Reduced at One Year in REDUCE FMR Trial
News | Heart Failure | September 28, 2018
Heart failure patients who received the Carillon Mitral Contour System in the REDUCE FMR clinical trial showed a...
Overlay Init